We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Nanoparticles Empower Potential Universal Flu Vaccine

By LabMedica International staff writers
Posted on 05 Feb 2018
Print article
Image: A colorized negative stained transmission electron micrograph (TEM) depicting flu virus ultrastructural morphology (Photo courtesy of the CDC).
Image: A colorized negative stained transmission electron micrograph (TEM) depicting flu virus ultrastructural morphology (Photo courtesy of the CDC).
A potential "universal" flu vaccine based on double-layered protein nanoparticles loaded with the invariable portion of viral hemagglutinin produced long-lasting immunity and fully protected mice against challenge with various strains of influenza A viruses.
 
Investigators at Georgia State University (Atlanta, USA) fabricated layered nanoparticles by inserting tetrameric M2e into protein nanoparticle cores and coating these cores with crosslinked headless hemagglutinin stalk proteins. M2e (ectodomain of influenza matrix protein 2) is highly conserved in both human and avian influenza A viruses. The low immunogenicity against natural M2e can be overcome by fusing M2e to an appropriate carrier particle. Protein carriers with representative headless hemagglutinin of two different phylogenetic groups were constructed and purified.
 
The investigators reported in the January 24, 2018, online edition of the journal Nature Communications that vaccinations with the resulting protein nanoparticles in mice induced robust long-lasting immunity, fully protecting the mice against challenges by influenza A viruses of the same group or both groups.
 
"What we wanted to do is to induce responses to this stalk part of the influenza surface glycoprotein, not the head part," said senior author Dr. Bao-Zhong Wang, associate professor of biomedical sciences at Georgia State University. "This way you are protected against different viruses because all influenza viruses share this stalk domain. However, this stalk domain itself is not stable, so we used a very special way to make this vaccine construct with the stalk domain and had success. We assembled this stalk domain into a protein nanoparticle as a vaccine. Once inside, the nanoparticle can protect this antigenic protein so it will not be degraded. Our immune cells have a good ability to take in this nanoparticle, so this nanoparticle is much, much better than a soluble protein to induce immune responses. We are developing a universal influenza vaccine that would not need to change the vaccine type every year because it is universal and can protect against any influenza virus."
 
In addition to their role in a universal flu vaccine, the physiologically activated disassembly of the protein nanoparticles after uptake into cells implies a wide potential for protein drug delivery and controlled release.
 
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.